Literature DB >> 12459037

Role of superoxide dismutase in survival of Leishmania within the macrophage.

Sanjay Ghosh1, Srikanta Goswami, Samit Adhya.   

Abstract

Intracellular parasitic protozoans of the genus Leishmania depend for their survival on the elaboration of enzymic and other mechanisms for evading toxic free-radical damage inflicted by their phagocytic macrophage host. One such mechanism may involve superoxide dismutase (SOD), which detoxifies reactive superoxide radicals produced by activated macrophages, but the role of this enzyme in parasite survival has not yet been demonstrated. We have cloned a SOD gene from L. tropica and generated SOD-deficient parasites by expressing the corresponding antisense RNA from an episomal vector. Such parasites have enhanced sensitivity to menadione and hydrogen peroxide in axenic culture, and a markedly reduced survival in mouse macrophages. These results indicate that SOD is a major determinant of intracellular survival of Leishmania.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12459037      PMCID: PMC1223130          DOI: 10.1042/BJ20021684

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Cloning and characterization of three differentially expressed peroxidoxin genes from Leishmania chagasi. Evidence for an enzymatic detoxification of hydroxyl radicals.

Authors:  S D Barr; L Gedamu
Journal:  J Biol Chem       Date:  2001-07-03       Impact factor: 5.157

2.  Iron- and manganese-containing superoxide dismutases can be distinguished by analysis of their primary structures.

Authors:  M W Parker; C C Blake
Journal:  FEBS Lett       Date:  1988-03-14       Impact factor: 4.124

Review 3.  The role of oxygen and its derivatives in microbial pathogenesis and host defense.

Authors:  L Beaman; B L Beaman
Journal:  Annu Rev Microbiol       Date:  1984       Impact factor: 15.500

4.  Leishmanial superoxide dismutase: a possible target for chemotherapy.

Authors:  S R Meshnick; J W Eaton
Journal:  Biochem Biophys Res Commun       Date:  1981-10-15       Impact factor: 3.575

5.  Superoxide dismutase: improved assays and an assay applicable to acrylamide gels.

Authors:  C Beauchamp; I Fridovich
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

6.  Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase.

Authors:  M U Shiloh; J D MacMicking; S Nicholson; J E Brause; S Potter; M Marino; F Fang; M Dinauer; C Nathan
Journal:  Immunity       Date:  1999-01       Impact factor: 31.745

7.  Response of Leishmania chagasi promastigotes to oxidant stress.

Authors:  M E Wilson; K A Andersen; B E Britigan
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

8.  Stable transfection of the human parasite Leishmania major delineates a 30-kilobase region sufficient for extrachromosomal replication and expression.

Authors:  G M Kapler; C M Coburn; S M Beverley
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

9.  Coxiella burnetii superoxide dismutase gene: cloning, sequencing, and expression in Escherichia coli.

Authors:  R A Heinzen; M E Frazier; L P Mallavia
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

10.  Import of small RNAs into Leishmania mitochondria in vitro.

Authors:  S Mahapatra; T Ghosh; S Adhya
Journal:  Nucleic Acids Res       Date:  1994-08-25       Impact factor: 16.971

View more
  38 in total

1.  Extracellular superoxide dismutase in insects: characterization, function, and interspecific variation in parasitoid wasp venom.

Authors:  Dominique Colinet; Dominique Cazes; Maya Belghazi; Jean-Luc Gatti; Marylène Poirié
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

2.  Iron superoxide dismutases targeted to the glycosomes of Leishmania chagasi are important for survival.

Authors:  Katherine A Plewes; Stephen D Barr; Lashitew Gedamu
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Experimental resistance to drug combinations in Leishmania donovani: metabolic and phenotypic adaptations.

Authors:  Maya Berg; Raquel García-Hernández; Bart Cuypers; Manu Vanaerschot; José I Manzano; José A Poveda; José A Ferragut; Santiago Castanys; Jean-Claude Dujardin; Francisco Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

4.  Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility.

Authors:  M Van den Kerkhof; L Van Bockstal; J F Gielis; P Delputte; P Cos; L Maes; Guy Caljon; Sarah Hendrickx
Journal:  Parasitol Res       Date:  2018-08-23       Impact factor: 2.289

Review 5.  Chemical Warfare at the Microorganismal Level: A Closer Look at the Superoxide Dismutase Enzymes of Pathogens.

Authors:  Sabrina S Schatzman; Valeria C Culotta
Journal:  ACS Infect Dis       Date:  2018-03-14       Impact factor: 5.084

Review 6.  Redox metabolism in mitochondria of trypanosomatids.

Authors:  Ana M Tomás; Helena Castro
Journal:  Antioxid Redox Signal       Date:  2012-11-15       Impact factor: 8.401

7.  Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.

Authors:  Marion Man-Ying Chan; Naga Suresh Adapala; Dunne Fong
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

8.  Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth.

Authors:  Nupur Kanti Das; Sudipta Biswas; Sunil Solanki; Chinmay K Mukhopadhyay
Journal:  Cell Microbiol       Date:  2008-09-24       Impact factor: 3.715

9.  Cloning and differential expression of manganese superoxide dismutase (Mn-SOD) of Trichinella pseudospiralis.

Authors:  W K Wu; C H Mak; R C Ko
Journal:  Parasitol Res       Date:  2007-10-23       Impact factor: 2.289

10.  Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.

Authors:  Mohammad Ali Danesh-Bahreini; Javad Shokri; Afshin Samiei; Eskandar Kamali-Sarvestani; Mohammad Barzegar-Jalali; Soliman Mohammadi-Samani
Journal:  Int J Nanomedicine       Date:  2011-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.